| Entry |
|
|---|
| Name |
Dacarbazine (JAN/USP/INN);
DTIC-Dome (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C6H10N6O
|
|---|
| Exact mass |
182.0916
|
|---|
| Mol weight |
182.18
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antineoplastic
DG01677 Alkylating agent
|
|---|
| Remark |
| Therapeutic category: | 4219 |
| Product (DG00680): | D00288<JP/US> |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Disease |
|
|---|
| Target |
DNA
RNA |
|---|
| Interaction |
|
|---|
| Structure map |
| map07040 | Antineoplastics - alkylating agents |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AX Other alkylating agents
L01AX04 Dacarbazine
D00288 Dacarbazine (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Antineoplastics
Alkylating Agents
Alkylating Agents, Other
Dacarbazine
D00288 Dacarbazine (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
421 Alkylating agents
4219 Others
D00288 Dacarbazine (JAN/USP/INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG00680 Dacarbazine
D00288 Dacarbazine
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG00680 Dacarbazine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 13
1 C8y C 19.2500 -18.5500
2 C8y C 19.2500 -19.9500
3 N5x N 20.5815 -20.3826
4 C8x C 21.4044 -19.2500
5 N4x N 20.5815 -18.1174
6 N2b N 18.0376 -17.8500
7 N2b N 16.8251 -18.5500
8 N1a N 16.8251 -19.9500
9 C5a C 18.0376 -20.6500
10 O5a O 18.0376 -22.0498
11 N1c N 15.5940 -17.8390
12 C1a C 14.3888 -18.5347
13 C1a C 15.5943 -16.4501
BOND 13
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 1 5 1
6 1 6 1
7 6 7 2
8 8 9 1
9 2 9 1
10 9 10 2
11 7 11 1
12 11 12 1
13 11 13 1
|
|---|
